Open access · OA via OpenAlex

Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease

Chukwunonso K. Nwabufo, Omozojie P. Aigbogun

Journal of Neurology · 2022 · ▲ 35 citations

Loss of proteostasis

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1007/s00415-022-11267-9
Canonical: link ↗
Fetched: 2026-10-27 MST

Cite this

APA

Nwabufo, C.K., & Aigbogun, O.P. (2022). Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease. <em>Journal of Neurology</em>. https://doi.org/10.1007/s00415-022-11267-9

Vancouver

Nwabufo CK, Aigbogun OP. Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease. Journal of Neurology. 2022. doi:10.1007/s00415-022-11267-9.

BibTeX

@article{chukwunonso2022Diagno, title = {Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease}, author = {Chukwunonso K. Nwabufo and Omozojie P. Aigbogun}, journal = {Journal of Neurology}, year = {2022}, doi = {10.1007/s00415-022-11267-9}, }